Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Aug;47(8):1786-92.
doi: 10.1023/a:1016532228836.

Endothelin content, expression, and receptor type in normal and diseased human gallbladder

Affiliations

Endothelin content, expression, and receptor type in normal and diseased human gallbladder

S A McCartney et al. Dig Dis Sci. 2002 Aug.

Abstract

The aims of this study were to characterize the endothelin (ET) system in human gallbladder by determining (1) the tissue content of ET-1 and ET-2 by ELISA; (2) the expression of mRNA of the ET precursors preproendothelin-1, -2, and -3; and (3) mRNA expression for the ETA and ETB receptors. Median content of ET-1/2 was significantly reduced in severely inflamed gallbladders compared to gallbladders with mild inflammation. There was an inverse correlation between content of ET-1/2 and inflammation score. mRNA for preproendothelin-2 was highly expressed in all samples, whereas mRNA for preproendothelin-1 was present in negligible quantities and mRNA for preproendothelin-3 was undetectable. mRNA for ETA receptors was expressed in all samples analyzed, whereas mRNA for ETB receptors was expressed at a much lower level. This study demonstrates the presence of ET-1/2 in human gallbladder. ET-1/2 content is decreased with increasing degrees of histological inflammation. ET-2 is likely to be the physiologically significant endothelin isopeptide expressed and ETA receptors appear to predominate in the human gallbladder.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1998 Jun 15;101(12):2881-8 - PubMed
    1. J Pharmacol Exp Ther. 1992 Feb;260(2):549-53 - PubMed
    1. Am J Physiol. 1994 Apr;266(4 Pt 1):G713-21 - PubMed
    1. Dig Dis Sci. 1989 Sep;34(9):1420-4 - PubMed
    1. Lancet. 1992 Feb 15;339(8790):381-5 - PubMed

Publication types

LinkOut - more resources